Association between uric acid and cardiovascular risk variables in a non-hospitalized population

Arquivos Brasileiros de Cardiologia

Volumn 96, Issue 3, 2011, Pages 212-218

  Barbosa, Monica Cristina Campos ^a   Brandão, Andréa Araujo ^a   Pozzan, Roberto ^a   Magalhães, Maria Eliane Campos ^a   Campana, Érika Maria Gonçalves ^a   Fonseca, Flavia Lopes ^a   Pizzi, Oswaldo Luiz ^a   de Freitas, Elizabete Viana ^a   Brandão, Ayrton Pires ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cardiovascular diseases epidemiology; Hypertension; Metabolic syndrome; Risk factors; Uric acid

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OBSERVATIONAL STUDY; SEX RATIO; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; BRAZIL; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INSULIN; KIDNEY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; URIC ACID; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 79955542212     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2011005000011     Document Type: Article

References (35)

1. Mohamed F. On chronic Bright's disease, and its essential symptoms. Lancet. 1879; 1: 399-401. apud:
2. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease and metabolic syndrome. Cleve Clin J Med. 2006; 73 (12): 1059-63.
3. Sunstrom J, Sullivan L, D'agostinho R, Levy D, Kannnel W, Vasan R. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005; 45 (1): 28-33.
4. Mellen PB, Bleyer AJ, Erlinger TP, Evans G, Nieto FJ, Wagenknecht L, et al. Serum acid uric predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006; 48 (6):1037-42.
5. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Litonjua AA, Vokonas P, et al. Uric acid and the development of hypertension: the Normative Aging Study. Hypertension. 2006; 48 (6): 1031-6.
6. Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension. 2007; 49 (2): 298-303.
7. Mazzali M, Hughes J, Kim Y, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001; 38 (5): 1101-6.
8. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal. 2002; 282 (6): F991-F7.
9. Nakagawa T, Hu H, Zhariov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose e-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006; 290 (3): F625-31.
10. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease and metabolic syndrome. Cleve Clin J Med. 2006; 73 (12): 1059-63.
11. Matthews DR, Hosker JP, Rudenki AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28 (7): 412-9.
12. Brandão AP, Nogueira AR, Oliveira JE, Guimarães JI, Suplicy H, Brandão AA. (orgs.)./Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005; 84 (supl 1): 3-28.
13. Mion Jr D, Kohlmann Jr O, Machado CA, Amodeo C, Gomes MAM, Praxedes JN, et al./ Sociedade Brasileira de Cardiologia. V Diretrizes brasileiras de hipertensão arterial. Arq Bras Cardiol. 2007; 89 (3): e24-e79.
14. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, et al. Serum uric acid and target organ damage in primary hypertension. Hypertension. 2005; 45 (5): 991-6.
15. Alper AB, Chen W, Yau L, Srinivans SR, Berenson G, Hamm LL. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension. 2005; 45 (1): 34-8.
16. Desai M, Santos R, Dalal D, Carvalho JA, Marten DR, Flynn JA, et al. Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. J Am Coll Cardiol. 2005; 95 (7): 865-8.
17. Choi HK, Ford ES. Prevalence of metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007; 120 (5): 442-7.
18. Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007; 115 (19): 2526-32.
19. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid as a risk factor for cardiovascular and all cause mortality in middle-ages men. Arch Intern Med. 2004; 164 (14): 1546-51.
20. Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Epidemiology. 1999; 10 (4): 391-7.
21. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999; 131 (1): 7-13.
22. Bengtsson C, Lapidus L, Stendhal C, Waldestrom J. Hyperuricemia and risk of cardiovascular disease and overall death: a 12-year follow-up of participants in the population study of women in Gothemburg, Sweden. Acta Med Scand. 1988; 224 (6): 549-55.
23. Taniguchi Y, Hayashi T, Tsumara K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. Hypertension. 2001; 19 (7): 1209-15.
24. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, et al. Serum acid uric and hypertension: the Olivetti Heart Study. J Hum Hypertens. 1994; 8 (9): 677-81.
25. Ishizaka N, Ishizaka I, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005; 25 (5): 1038-44.
26. Kawada T, Otsuka T, Katsumata M, Suzuki H. Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese working men. J Cardiometab Syndr. 2007; 2 (3): 158-62.
27. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007; 18 (1): 287-92.
28. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol. 2006; 17 (5): 1466-71.
29. Ministério da Saúde. Secretaria Executiva. DATASUS. Indicadores e dados básicos do Brasil. Brasília; 2007. [Acesso em 2009 nov 9]. Disponível em http://www.datasus.gov.br
30. Conen D, Wietlisbach V, Bovet P, Shamaye C, Riesen W, Paccand F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in developing country. BMC Public Health. 2004 Mar 25; 4-9.
31. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 2000; 148 (1): 131-9.
32. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron complexes: a new aspect of the antioxidant functions of uric acid. Biochemist J. 1986; 235 (3): 747-54.
33. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical- caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981; 78 (11): 6858-62.
34. Coutinho TA, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ. Association of serum uric acid with markers of inflammation, metabolic syndrome and subclinical coronary atherosclerosis. Am J Hypertens. 2007; 20 (1): 83-9.
35. Franco GPP, Scala LCN, Alves CJ, França VA, Casarell T, Jardim PC. Síndrome metabólica em hipertensos de Cuiabá-MT: prevalência e fatores de risco. Arq Bras Cardiol. 2009; 92 (6): 437-42.